CPSC2023-03-09
Sandoz Recalls Aprepitant Capsules and Lidocaine and Prilocaine Cream Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream)
Hazard
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Remedy
Consumers should immediately secure the medications out of the sight and reach of children and contact Sandoz for a free child resistant pouch to store the products. Once the medication is secured, consumers can continue to use the medication as directed.
Sold at
Pharmacies nationwide as a prescribed medicine from October 2020 through January 2023. The prices of the medications varied based on health insurance terms and other factors.
Affected count
About 156,750
Injuries reported
None reported
Manufactured in
Slovenia (Aprepitant Capsules), United States (Lidocaine and Prilocaine cream)
Remedy type
New Instructions
Products
Aprepitant capsules and Lidocaine and Prilocaine cream
Consumer contact
Sandoz toll-free at 866-300-2207 from 8 a.m. to 5 p.m. ET Monday through Friday, email at Sandoz6768@sedgwick.com or online at https://www.us.sandoz.com/patients-customers/product-safety-notices or www.us.sandoz.com and click on "Product Safety Notices" below the carousel for more information.
Official notice
https://www.cpsc.gov/Recalls/2023/Sandoz-Recalls-Aprepitant-Capsules-and-Lidocaine-and-Prilocaine-Cream-Prescription-Drugs-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Risk-of-PoisoningDon't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief